Keywords: %FVC; percent predicted forced vital capacity; 6MWT; six-minute walk test; Ab +; antibody positive; Ab â; antibody negative; AEs; adverse events; CSA; conformation-specific antibody assay; ELISA; enzyme-linked immunosorbent assay; FVC; forced vital ca
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
The effect of galsulfase enzyme replacement therapy on the growth of patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
Keywords: ASB; Arylsulfatase B; CDC; Centers for Disease Control and Prevention; ERT; Enzyme replacement therapy; GAG; Glycosaminoglycans; MPS VI; Mucopolysaccharidosis VI; uGAG; Urinary glycosaminoglycans; Mucopolysaccharidosis; Mucopolysaccharidosis VI; Maroteaux
Mucopolysaccharidosis Type I Newborn Screening: Best Practices for Diagnosis and Management
Keywords: CNS; Central nervous system; DBS; Dried blood spot; ERT; Enzyme replacement therapy; GAG; Glycosaminoglycan; HSCT; Hematopoietic stem cell transplantation; IDUA; α-L-iduronidase; MPS; Mucopolysaccharidoses; MPS I; Mucopolysaccharidosis type I; MRI; Magne
A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA
Keywords: AE; adverse event; BSID-III; Bayley Scales of Infant and Toddler Development, Third Edition; CSF; cerebrospinal fluid; CNS; central nervous system; DQ; developmental quotient; EC; Enzyme Commission; ELISA; enzyme-linked immunosorbent assay; GAG; glycosami
Original ArticlesOutcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type I
Keywords: MPS I; mucopolysaccharidosis type I; enzyme replacement therapy; laronidase; 6MWT; 6-minute walk test; ERT; Enzyme replacement therapy; FVC; Forced vital capacity; GAG; Glycosaminoglycan; MPS I; Mucopolysaccharidosis type I; uGAG; Urinary glycosaminoglyca
The laboratory diagnosis of mucopolysaccharidosis III (Sanfilippo syndrome): A changing landscape
Keywords: DMB; dimethylmethylene blue; GAG; glycosaminoglycan; HPLC; high-performance liquid chromatography; LC; liquid chromatography; MPS; mucopolysaccharidosis; MS/MS; tandem mass spectrometry; NRE; non-reducing end; uGAG; urinary glycosaminoglycan; Mucopolysacc
Current diagnosis and management of mucopolysaccharidosis VI in the Asia-Pacific region
Keywords: ARSB; arylsulfatase B gene; ASB; arylsulfatase B; BMT; bone marrow transplantation; DBS; dry blood spot; dx; diagnosis; ERT; enzyme replacement therapy; GAG; glycosaminoglycan; HSCT; hematopoietic stem cell transplantation; LSDP; Life Saving Drugs Program